Developer docs
API playgroundTry for free, no card

Search company profiles

Bloom Diagnostics

Full company profile

uuid0004w6a

Namestring
Bloom Diagnostics
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Bloom Diagnostics is a Switzerland-based, for-profit health technology company founded in 2018 and headquartered in Zürich. The company develops consumer-facing smart medical diagnostic tests by combining diagnostic technology with medical knowledge and data, targeting end consumers directly rather than clinical laboratories. Its product architecture appears to be an integrated hardware device paired with a software layer, evidenced by the presence of separate heads of hardware and software on the leadership team.

The company has raised approximately $28.2 million across five disclosed funding rounds between 2018 and 2022, with named institutional investors including Speedinvest, Walter Ventures, Dutch L'Arche BV, and Astor Perkins. The largest single financing was approximately $11.1M in May 2020. In May 2018, Bloom also acquired ivary for an undisclosed amount, signaling an early capability tuck-in during the company's founding phase.

Bloom operates with 101-250 employees and a full executive team led by Angelica Kohlmann, MD PhD as Executive Chairman, with dedicated chiefs covering commercial (CCO), financial (CFO), operational (COO), product (CPO), and medical (CMO) functions. No customer logos, named customer segments, pricing, distribution channels, or revenue figures are disclosed in the available input, and the company remains private with no IPO or public valuation events identified.

Short descriptiontext

Bloom Diagnostics is a Zürich-based health technology company founded in 2018 that develops consumer-facing smart medical diagnostic tests, combining proprietary diagnostic hardware with software-based interpretation and data analytics for at-home use.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersZurich, Switzerland
HQ citystring
Zurich
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
consumer diagnostics, at-home medical tests, smart diagnostic devices, point-of-care testing, digital health testing
Industry4 codes
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Consumer Medical Diagnostics
Social media profiles2 records
Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bloom Diagnostics builds smart, consumer-facing medical diagnostic tests that combine proprietary hardware (a reader device) and a software platform (a companion app) with medical knowledge and data to enable individuals to run tests at home and obtain medically interpreted results. Core sellable items include branded diagnostic test kits and the associated connected reader hardware.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Bloom Smart Medical Tests for Consumers
CategoryConsumer medical diagnostics
Description

Smart medical diagnostic tests for individual consumers that combine diagnostics technology with medical knowledge and data, intended for at-home self-testing.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US direct-to-consumer at-home testing brand offering screens for STIs, fertility, and general wellness — competes with Bloom for consumer self-testing share across multiple categories.

TypeDirect peer
Description

End-to-end at-home testing provider with kits, lab processing, and digital results — overlaps with Bloom in the consumer self-testing journey and DTC distribution motion.

TypeDirect peer
Description

UK-based at-home blood testing subscription service offering biomarker tracking with digital results — comparable in offering consumer IVD tests with a recurring health-data model in a similar European regulatory environment.

TypeDirect peer
Description

Direct-to-consumer at-home testing brand offering a broad menu of consumer diagnostics, combining test kits with digital results — competing with Bloom for the same consumer self-testing channel.

TypeEmerging player
Description

US startup developing on-demand dried-blood-spot sample collection devices that integrate into clinical workflows — overlapping with Bloom in connected home sample-to-data diagnostics.

TypeDirect peer
Description

Israel-based company turning smartphone cameras into clinical-grade diagnostic tests (e.g., urinalysis, wound care) — a closely comparable connected-at-home diagnostic device + assay model.

7Cue Health
TypeDirect peer
Description

US-based connected at-home diagnostic reader company offering molecular test cartridges paired with a smartphone app and digital data loop — the closest comparable to Bloom's smart-test, consumer-grade model.

TypeBroad incumbent
Description

Global IVD manufacturer increasingly moving into decentralized and connected diagnostics — relevant broader incumbent whose moves affect pricing and regulatory dynamics for smaller players like Bloom.

TypeBroad incumbent
Description

Global diagnostics leader providing reference instruments, assays, and increasingly self-testing solutions — comparable in the IVD category, with greater geographic reach and capital depth than Bloom.

TypeBroad incumbent
Description

Large, publicly-traded consumer genetics and health testing brand with deep brand recognition in self-test diagnostics — adjacent competitor that defines consumer expectations for direct-to-consumer testing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bloom Diagnostics

Consumer Medical Diagnosticsbloomdiagnostics.com

Bloom Diagnostics is a Zürich-based health technology company founded in 2018 that develops consumer-facing smart medical diagnostic tests, combining proprietary diagnostic hardware with software-based interpretation and data analytics for at-home use.

What Bloom Diagnostics does

Bloom Diagnostics is a Switzerland-based, for-profit health technology company founded in 2018 and headquartered in Zürich. The company develops consumer-facing smart medical diagnostic tests by combining diagnostic technology with medical knowledge and data, targeting end consumers directly rather than clinical laboratories. Its product architecture appears to be an integrated hardware device paired with a software layer, evidenced by the presence of separate heads of hardware and software on the leadership team.

The company has raised approximately $28.2 million across five disclosed funding rounds between 2018 and 2022, with named institutional investors including Speedinvest, Walter Ventures, Dutch L'Arche BV, and Astor Perkins. The largest single financing was approximately $11.1M in May 2020. In May 2018, Bloom also acquired ivary for an undisclosed amount, signaling an early capability tuck-in during the company's founding phase.

Bloom operates with 101-250 employees and a full executive team led by Angelica Kohlmann, MD PhD as Executive Chairman, with dedicated chiefs covering commercial (CCO), financial (CFO), operational (COO), product (CPO), and medical (CMO) functions. No customer logos, named customer segments, pricing, distribution channels, or revenue figures are disclosed in the available input, and the company remains private with no IPO or public valuation events identified.

Bloom Diagnostics firmographics

Firmographics
Name
Bloom Diagnostics
Website
https://bloomdiagnostics.com
Company type
Private
Founded year
2018
Headcount range
1–10 employees
Short description
Bloom Diagnostics is a Zürich-based health technology company founded in 2018 that develops consumer-facing smart medical diagnostic tests, combining proprietary diagnostic hardware with software-based interpretation and data analytics for at-home use.
Ownership category
akta.pro rank

Bloom Diagnostics industry classification

Industry
Product category
Consumer Medical Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Consumer diagnostics
  • At-home medical tests
  • Smart diagnostic devices
  • Point-of-care testing
  • Digital health testing

Where Bloom Diagnostics is headquartered

Location

Headquarters

HQ city
Zurich
HQ country
Switzerland
HQ region
Europe

Markets served

Bloom Diagnostics business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Others

Bloom Diagnostics product offering

Product offering

Core offering

Bloom Diagnostics builds smart, consumer-facing medical diagnostic tests that combine proprietary hardware (a reader device) and a software platform (a companion app) with medical knowledge and data to enable individuals to run tests at home and obtain medically interpreted results. Core sellable items include branded diagnostic test kits and the associated connected reader hardware.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bloom Smart Medical Tests for Consumers Smart medical diagnostic tests for individual consumers that combine diagnostics technology with medical knowledge and data, intended for at-home self-testing.

Companies that use Bloom Diagnostics

Customer profile

Ideal customer profiles1 record

Bloom Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bloom Diagnostics partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Bloom Diagnostics competitors and assessment

Company assessment

Direct peers

  • myLAB Box: US direct-to-consumer at-home testing brand offering screens for STIs, fertility, and general wellness — competes with Bloom for consumer self-testing share across multiple categories.
  • LetsGetChecked: End-to-end at-home testing provider with kits, lab processing, and digital results — overlaps with Bloom in the consumer self-testing journey and DTC distribution motion.
  • Thriva: UK-based at-home blood testing subscription service offering biomarker tracking with digital results — comparable in offering consumer IVD tests with a recurring health-data model in a similar European regulatory environment.
  • Everlywell: Direct-to-consumer at-home testing brand offering a broad menu of consumer diagnostics, combining test kits with digital results — competing with Bloom for the same consumer self-testing channel.
  • Healthy.io: Israel-based company turning smartphone cameras into clinical-grade diagnostic tests (e.g., urinalysis, wound care) — a closely comparable connected-at-home diagnostic device + assay model.
  • Cue Health: US-based connected at-home diagnostic reader company offering molecular test cartridges paired with a smartphone app and digital data loop — the closest comparable to Bloom's smart-test, consumer-grade model.

Emerging players

  • Tasso: US startup developing on-demand dried-blood-spot sample collection devices that integrate into clinical workflows — overlapping with Bloom in connected home sample-to-data diagnostics.

Broad incumbents

  • Biomérieux / bioMérieux Connect: Global IVD manufacturer increasingly moving into decentralized and connected diagnostics — relevant broader incumbent whose moves affect pricing and regulatory dynamics for smaller players like Bloom.
  • Roche (Diagnostics): Global diagnostics leader providing reference instruments, assays, and increasingly self-testing solutions — comparable in the IVD category, with greater geographic reach and capital depth than Bloom.
  • 23andMe: Large, publicly-traded consumer genetics and health testing brand with deep brand recognition in self-test diagnostics — adjacent competitor that defines consumer expectations for direct-to-consumer testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Bloom Diagnostics social profiles

Digital presence

Bloom Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bloom Diagnostics leadership team

Management profile

Number of profiles

Profiles8 records

Bloom Diagnostics funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bloom Diagnostics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bloom Diagnostics

What does Bloom Diagnostics do?

Bloom Diagnostics builds smart, consumer-facing medical diagnostic tests that combine proprietary hardware (a reader device) and a software platform (a companion app) with medical knowledge and data to enable individuals to run tests at home and obtain medically interpreted results. Core sellable items include branded diagnostic test kits and the associated connected reader hardware.

When was Bloom Diagnostics founded?

Bloom Diagnostics was founded in 2018. It employs 1 to 10 people.

Where is Bloom Diagnostics based?

Bloom Diagnostics is headquartered in Zurich, Switzerland, in the Europe region.

Who are Bloom Diagnostics's main competitors?

Direct peers on record are myLAB Box, LetsGetChecked, Thriva, Everlywell, Healthy.io and Cue Health. Tasso is listed as an emerging player. Broad incumbents are Biomérieux / bioMérieux Connect, Roche (Diagnostics) and 23andMe.

Does Bloom Diagnostics have an API?

No public API is recorded for Bloom Diagnostics.

What industry is Bloom Diagnostics in?

Bloom Diagnostics's product category is Consumer Medical Diagnostics. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLAIADAO, Home Diagnostic & Self-Test OTC Kits. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chBloom Diagnostics’ Smart fertility test gets European approvalBloom Diagnostics received European approval for its Bloom Ovarian Reserve Test, which measures Anti-Müllerian Hormone (AMH) via a single-use self-testing kit. The test is for women 18-39 and provides results in 20 minutes via the Bloom App, supporting fertility treatments. The company plans to expand its Bloom System with more health tests.startupticker.chBloom Diagnostics opens first flagship store in ZurichBloom Diagnostics opened its first flagship store in Zurich's pedestrian zone, offering the Bloom Lab for at-home testing. The system provides a finger-prick ferritin test with results in ten minutes, and additional tests like AMH and TSH are in pipeline. The company aims to democratize healthcare access and relieve pressure on medical systems.startupticker.chBloom Diagnostics’ test reaches thousands in a few daysBloom Diagnostics launched its smart COVID test kit in the European Union, which has facilitated thousands of tests. The CE Mark certified device delivers results in ten minutes and is awaiting FDA approval for the US market. The company plans to expand its Bloom Analytics platform globally beyond 2021.startupticker.chBloom Diagnostics launches smart COVID-19 antibody testBloom Diagnostics launched its smart COVID-19 antibody testing device after receiving $11.7 million in Series B funding. The device detects antibodies within ten minutes and is approved for professional use in the EU, with home self-testing seeking approval in Europe and the US. The company plans further tests on its Bloom System platform.startupticker.chBloom Diagnostics off to a good start with $11.7 millionBloom Diagnostics raised $11.7 million in Series B funding led by Thomas Pfisterer from WILD Group. The Medtech startup will use the proceeds for R&D and expansion in Europe and the US. It plans to launch its COVID-19 antibody test for professionals in Q3 2020.Tech.euSwiss medtech startup Bloom Diagnostics launches new testing system after €10 million Series BSwiss medtech Bloom Diagnostics launched its testing device after closing a €10 million Series B round in May. The funding, led by WILD Group, will support R&D and expansion in Europe and the US. The company also plans to integrate a Covid-19 antibody test for professionals.